🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
05/09/2007 0,3626 USD
06/06/2007 0,3626 USD
07/03/2007 0,3626 USD
06/12/2006 0,3626 USD
30/08/2006 0,3626 USD
31/05/2006 0,3626 USD
08/03/2006 0,3626 USD
30/11/2005 0,3626 USD
31/08/2005 0,3626 USD
01/06/2005 0,3626 USD
02/03/2005 0,3626 USD
01/12/2004 0,3626 USD
01/09/2004 0,3626 USD
02/06/2004 0,3531 USD
03/03/2004 0,3531 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/05/2009 24,79 25,24 24,61 24,90 +1,24% 2,54% 16.231.005
19/05/2009 24,56 24,71 24,14 24,59 +0,12% 2,33% 16.363.053
18/05/2009 24,44 24,62 24,06 24,56 +1,06% 2,26% 15.679.023
15/05/2009 25,05 25,05 24,18 24,30 -2,23% 3,47% 18.947.840
14/05/2009 24,59 25,04 24,48 24,86 +1,48% 2,29% 21.327.114
13/05/2009 23,75 25,05 23,71 24,49 +2,76% 5,62% 26.484.846
12/05/2009 23,38 24,09 23,17 23,84 +2,38% 3,96% 24.452.250
11/05/2009 23,45 23,66 23,22 23,28 -1,69% 1,91% 16.962.614
08/05/2009 24,19 24,34 23,52 23,68 -1,55% 3,39% 19.570.038
07/05/2009 23,57 24,40 23,33 24,06 +2,44% 4,53% 28.997.846
06/05/2009 23,55 23,79 23,13 23,48 +0,08% 2,80% 23.711.000
05/05/2009 23,38 23,84 23,24 23,46 -0,12% 2,53% 17.891.875
04/05/2009 23,47 23,70 23,22 23,49 +1,32% 2,07% 20.048.659
01/05/2009 23,12 23,26 22,72 23,19 +0,25% 2,35% 15.816.835
30/04/2009 23,02 23,45 22,90 23,13 +1,42% 2,40% 29.434.023
29/04/2009 22,17 22,96 22,09 22,81 +3,15% 3,92% 29.254.710
28/04/2009 22,35 22,54 21,95 22,11 -1,15% 2,65% 24.059.041
27/04/2009 22,33 22,61 22,15 22,37 -0,04% 2,05% 16.986.718
24/04/2009 22,20 22,47 21,99 22,38 +0,95% 2,15% 23.124.749
23/04/2009 22,01 22,26 21,60 22,17 +1,13% 2,99% 37.293.290
22/04/2009 22,33 22,42 21,31 21,92 -2,42% 5,00% 55.546.934
21/04/2009 23,29 23,43 21,88 22,46 -6,66% 6,64% 42.417.590
20/04/2009 24,33 24,72 24,04 24,06 -1,98% 2,82% 13.786.650
17/04/2009 24,71 25,28 24,47 24,55 -0,46% 3,28% 19.709.212
16/04/2009 25,23 25,30 24,20 24,67 -1,52% 4,35% 19.463.980
15/04/2009 24,45 25,18 24,36 25,05 +2,22% 3,36% 16.521.406
14/04/2009 24,72 24,98 24,40 24,50 -1,42% 2,35% 13.162.042
13/04/2009 24,92 25,31 24,69 24,86 -0,95% 2,49% 11.654.494
09/04/2009 26,01 26,19 24,89 25,10 -1,72% 5,03% 15.819.979
08/04/2009 25,17 25,53 25,01 25,53 +1,87% 2,09% 11.073.168